Nutex Health Inc. (NUTX) 주식 분석

회사 개요

Nutex Health Inc. operates as a healthcare services and operations company within the United States, delivering medical care through a diversified portfolio that includes hospital operations, population health management, and real estate assets. The company is categorized within the Healthcare sector and the Medical Care Facilities industry, positioning it as a provider of essential medical infrastructure and specialized care delivery systems. With a market capitalization of $727.70M, annual revenue of $875.26M, and an employee base of 944, the organization maintains a significant physical footprint and operational capacity in the regional healthcare landscape. These valuation and revenue figures indicate that the company is a mid-to-large-cap entity capable of managing complex healthcare networks, yet the scale also reflects the capital-intensive nature of developing and operating micro hospitals and specialty facilities.

재무 건전성

Nutex Health Inc. reported a trailing twelve-month revenue of $875.26M and a net income of $70.79M, resulting in an EBITDA of $413.16M, which highlights a substantial gap between top-line revenue and bottom-line profit indicative of a heavy cost structure typical of healthcare operations. The company generated free cash flow of $152.81M, suggesting a robust capacity to fund capital expenditures, service debt obligations, or pursue strategic acquisitions without relying solely on external financing. Gross margin stands at 53.8%, reflecting the pricing power and efficiency of the hospital segment, while the operating margin reaches an exceptionally high 97.5%, indicating effective cost control in administrative functions, though the profit margin of 8.1% reveals that non-operating expenses or interest costs significantly compress the final earnings. On the balance sheet, the company holds $185.57M in cash against $351.39M in debt, supported by a debt-to-equity ratio of 82.99, which points to a leveraged capital structure where equity financing is minimal relative to liabilities. The current ratio of 3.41 demonstrates strong short-term liquidity, as current assets significantly exceed current liabilities, providing ample buffer to meet immediate financial obligations. Furthermore, the return on equity of 58.9% and return on assets of 31.2% reveal highly effective management in generating returns on the capital invested, although these metrics are amplified by the company's high leverage and low equity base.

밸류에이션 평가

The valuation of Nutex Health Inc. presents a trailing P/E ratio of 9.82 and a forward P/E of 5.06, implying that the market expects a significant contraction in earnings in the near future, as the forward multiple is less than half of the trailing multiple. The price-to-book ratio is 2.21, indicating that the stock trades at a premium over its book value, which suggests investors are pricing in growth potential or intangible assets beyond the tangible net assets listed on the balance sheet. Alternative valuation metrics such as the price-to-sales ratio of 0.83 and an EV/EBITDA of 2.36 suggest the company is valued at less than one dollar of sales per share and has an enterprise value relative to earnings that is relatively low compared to historical averages for healthcare operators. The 52-week high was $193.07 and the low was $77.21, and given the current market dynamics reflected in the P/E compression, the stock is trading at a level that suggests a significant discount relative to its recent 52-week high, reflecting current market sentiment regarding its earnings trajectory. The beta value of 2.02 indicates that the stock price is twice as volatile as the broader market, meaning that price swings in Nutex Health Inc. are expected to be magnified relative to general market movements.

Growth & Income

Nutex Health Inc. experienced a revenue growth rate of -41.1% year-over-year and an earnings growth rate of -86.2% year-over-year, indicating that earnings are declining at a much faster pace than revenue, which points to severe cost pressures, margin compression, or one-time charges impacting profitability disproportionately to top-line sales. The company does not pay a dividend, as evidenced by a dividend yield of N/A and a payout ratio of 0.0%, meaning that instead of distributing income to shareholders, the firm retains all earnings to potentially fund operations, pay down debt, or reinvest in its hospital and real estate segments. The absence of a dividend yield combined with negative growth metrics suggests a capital preservation strategy or a focus on turnaround efforts rather than shareholder income distribution. Overall, the growth and income profile is characterized by significant contraction in both revenue and earnings with no current income generation through dividends, reflecting a challenging operational environment for this specific healthcare facility operator.